Om oss

Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Nettsted
http://www.tevapharm.com
Bransje
Farmasøytisk produksjon
Bedriftsstørrelse
10 001+ ansatte
Hovedkontor
Tel-Aviv
Type
Åpent aksjeselskap
Spesialiteter
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, oncology

Beliggenheter

Ansatte i Teva Pharmaceuticals

Oppdateringer

Tilknyttede sider

Tilsvarende sider

TEVA

NYSE

$17.28

Åpne
17.13
17.065
17.395

Bing

Finansiering

Teva Pharmaceuticals 3 av trunder

Siste runde

Egenkapital etter børsnotering

$100,000,000.00

Investorer

Royalty Pharma
Se mer informasjon på Crunchbase